Works matching IS 0167-6806 AND VI 180 AND IP 3 AND DT 2020


Results: 26
    1
    2
    4
    5

    A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2020, v. 180, n. 3, p. 715, doi. 10.1007/s10549-020-05590-w
    By:
    • Ishiguro, Hiroshi;
    • Masuda, Norikazu;
    • Sato, Nobuaki;
    • Higaki, Kenji;
    • Morimoto, Takashi;
    • Yanagita, Yasuhiro;
    • Mizutani, Makiko;
    • Ohtani, Shoichiro;
    • Kaneko, Koji;
    • Fujisawa, Tomomi;
    • Takahashi, Masato;
    • Kadoya, Takayuki;
    • Matsunami, Nobuki;
    • Yamamoto, Yutaka;
    • Ohno, Shinji;
    • Takano, Toshimi;
    • Morita, Satoshi;
    • Tanaka-Mizuno, Sachiko;
    • Toi, Masakazu
    Publication type:
    Article
    6
    8
    9

    Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy.

    Published in:
    Breast Cancer Research & Treatment, 2020, v. 180, n. 3, p. 707, doi. 10.1007/s10549-020-05584-8
    By:
    • Jennaro, Theodore S.;
    • Fang, Fang;
    • Kidwell, Kelley M.;
    • Smith, Ellen M. Lavoie;
    • Vangipuram, Kiran;
    • Burness, Monika L.;
    • Griggs, Jennifer J.;
    • Van Poznak, Catherine;
    • Hayes, Daniel F.;
    • Henry, N. Lynn;
    • Hertz, Daniel L.
    Publication type:
    Article
    10
    11
    12
    13

    The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience.

    Published in:
    Breast Cancer Research & Treatment, 2020, v. 180, n. 3, p. 809, doi. 10.1007/s10549-020-05578-6
    By:
    • Crolley, Valerie E.;
    • Marashi, Husam;
    • Rawther, Shabbir;
    • Sirohi, Bhawna;
    • Parton, Marina;
    • Graham, Janine;
    • Vinayan, Anup;
    • Sutherland, Stephanie;
    • Rigg, Anne;
    • Wadhawan, Anshu;
    • Harper-Wynne, Catherine;
    • Spurrell, Emma;
    • Bond, Hannah;
    • Raja, Fharat;
    • King, Judy
    Publication type:
    Article
    14
    15
    16

    G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2020, v. 180, n. 3, p. 635, doi. 10.1007/s10549-020-05575-9
    By:
    • Andreano, Kaitlyn J.;
    • Wardell, Suzanne E.;
    • Baker, Jennifer G.;
    • Desautels, Taylor K.;
    • Baldi, Robert;
    • Chao, Christina A.;
    • Heetderks, Kendall A.;
    • Bae, Yeeun;
    • Xiong, Rui;
    • Tonetti, Debra A.;
    • Gutgesell, Lauren M.;
    • Zhao, Jiong;
    • Sorrentino, Jessica A.;
    • Thompson, Delita A.;
    • Bisi, John E.;
    • Strum, Jay C.;
    • Thatcher, Gregory R. J.;
    • Norris, John D.
    Publication type:
    Article
    17
    18
    19
    20
    21

    Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.

    Published in:
    Breast Cancer Research & Treatment, 2020, v. 180, n. 3, p. 675, doi. 10.1007/s10549-020-05567-9
    By:
    • van Hellemond, Irene E. G.;
    • Smorenburg, Carolien H.;
    • Peer, Petronella G. M.;
    • Swinkels, Astrid C. P.;
    • Seynaeve, Caroline M.;
    • van der Sangen, Maurice J. C.;
    • Kroep, Judith R.;
    • de Graaf, Hiltje;
    • Honkoop, Aafke H.;
    • Erdkamp, Frans L. G.;
    • van den Berkmortel, Franchette W. P. J.;
    • de Roos, Wilfred K.;
    • Linn, Sabine C.;
    • Imholz, Alexander L. T.;
    • de Boer, Maaike;
    • Tjan-Heijnen, Vivianne C. G.
    Publication type:
    Article
    22
    23
    24
    25
    26